Pharma News

Keep updating your pharma knowledge
30 Jul 2017

Panacea Biotec’s collaboration agreement with Bionpharma to develop 7 complex generics

Panacea Biotec has entered into joint collaboration for development, license, manufacturing, supply and sales of 7 complex generic pharmaceutical products with Bionpharma Inc., a generic pharmaceutical company based in the United States. These 7 ANDAs are currently under development at Panacea Biotec, representing a total estimated market potential of more than US$ 800 million.

Deal Analysis:

  • As per the collaboration agreement, Bionpharma Inc. will be responsible for importation, warehousing, sales and distribution of these ANDAs in the US and its territories.
  • Panacea will be responsible for development, filling, registration manufacturing and supply of these ANDAs.
  • Further, under this agreement, both companies intend to expand the scope of their alliance by adding new products to the collaboration from time to time.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!